Nanosystems for brain targeting of antipsychotic drugs: an update on the most promising nanocarriers for increased bioavailability and therapeutic efficacy

HIGHLIGHTS

• who: Maria Daniela Ferreira et al. from the Department, Faculty Pharmacy the University, University have published the Article: Nanosystems for Brain Targeting of Antipsychotic Drugs: An Update on the Most Promising Nanocarriers for Increased Bioavailability and Therapeutic Efficacy, in the Journal: Pharmaceutics 2023, 678 of /2023/

SUMMARY

The first-line treatment for both schizophrenia and bipolar disorder is the prescription of antipsychotic drugs. Antipsychotic drugs also exhibit a variety of affinities towards other receptors, such as serotoninergic, cholinergic, adrenergic and histaminergic receptors, which leads to each antipsychotic drug molecule having a unique action . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.